share_log

JP Morgan Maintains Neutral on Molecular Partners, Lowers Price Target to $4.5

Benzinga ·  Dec 5, 2023 10:48

JP Morgan analyst Richard Vosser maintains Molecular Partners (NASDAQ:MOLN) with a Neutral and lowers the price target from $6.6 to $4.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment